Fact: This is not true
The drug is in the same class of GLP-1 medications as Ozempic, Wegovy, Mounjaro, and Zepbound weekly injections that upended the weight-loss industry but in pill form
Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications originally developed to manage type 2 diabetes and, more recently, approved for chronic weight management
These are not insignificant numbers, and anyone starting a retatrutide protocol for weight loss needs to understand them upfront
Eur J Endocrinol, 139(5):552-561
Generally, people want results, and people are getting them faster, in a more tangible manner, when it comes to ingestible beauty